The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology

Giorgio Zauli, Paola Secchiero

Research output: Contribution to journalArticle

Abstract

TRAIL is a member of the tumor necrosis factor superfamily that interacts with an unusually complex receptor system, comprising transmembrane (TRAIL-R1, -R2, -R3 and -R4) and soluble (osteoprotegerin) receptors. TRAIL has received considerable attention because of the finding that many cancer cell types are sensitive to TRAIL-induced apoptosis. However, increasing experimental evidence shows that TRAIL exhibits regulatory roles in various normal tissues, as well. Although the best-characterized biological activity of TRAIL is in the homeostatic regulation of the immune system, in this review we have summarized and discussed the physiological function of TRAIL and its receptors, in normal hematopoiesis and vascular physiopathology.

Original languageEnglish
Pages (from-to)245-257
Number of pages13
JournalCytokine and Growth Factor Reviews
Volume17
Issue number4
DOIs
Publication statusPublished - Aug 2006

Fingerprint

Cytology
TNF-Related Apoptosis-Inducing Ligand Receptors
Osteoprotegerin
Immune system
Endothelial cells
Hematopoiesis
Bioactivity
Blood Vessels
Cell Biology
Immune System
Endothelial Cells
Tumor Necrosis Factor-alpha
Cells
Tissue
Apoptosis
Neoplasms

Keywords

  • Endothelial cells
  • Hematopoiesis
  • OPG
  • TRAIL
  • TRAIL receptors

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology
  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy

Cite this

The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology. / Zauli, Giorgio; Secchiero, Paola.

In: Cytokine and Growth Factor Reviews, Vol. 17, No. 4, 08.2006, p. 245-257.

Research output: Contribution to journalArticle

@article{2c868f7165c249f0a422b7bc0bc79fc3,
title = "The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology",
abstract = "TRAIL is a member of the tumor necrosis factor superfamily that interacts with an unusually complex receptor system, comprising transmembrane (TRAIL-R1, -R2, -R3 and -R4) and soluble (osteoprotegerin) receptors. TRAIL has received considerable attention because of the finding that many cancer cell types are sensitive to TRAIL-induced apoptosis. However, increasing experimental evidence shows that TRAIL exhibits regulatory roles in various normal tissues, as well. Although the best-characterized biological activity of TRAIL is in the homeostatic regulation of the immune system, in this review we have summarized and discussed the physiological function of TRAIL and its receptors, in normal hematopoiesis and vascular physiopathology.",
keywords = "Endothelial cells, Hematopoiesis, OPG, TRAIL, TRAIL receptors",
author = "Giorgio Zauli and Paola Secchiero",
year = "2006",
month = "8",
doi = "10.1016/j.cytogfr.2006.04.002",
language = "English",
volume = "17",
pages = "245--257",
journal = "Cytokine and Growth Factor Reviews",
issn = "1359-6101",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology

AU - Zauli, Giorgio

AU - Secchiero, Paola

PY - 2006/8

Y1 - 2006/8

N2 - TRAIL is a member of the tumor necrosis factor superfamily that interacts with an unusually complex receptor system, comprising transmembrane (TRAIL-R1, -R2, -R3 and -R4) and soluble (osteoprotegerin) receptors. TRAIL has received considerable attention because of the finding that many cancer cell types are sensitive to TRAIL-induced apoptosis. However, increasing experimental evidence shows that TRAIL exhibits regulatory roles in various normal tissues, as well. Although the best-characterized biological activity of TRAIL is in the homeostatic regulation of the immune system, in this review we have summarized and discussed the physiological function of TRAIL and its receptors, in normal hematopoiesis and vascular physiopathology.

AB - TRAIL is a member of the tumor necrosis factor superfamily that interacts with an unusually complex receptor system, comprising transmembrane (TRAIL-R1, -R2, -R3 and -R4) and soluble (osteoprotegerin) receptors. TRAIL has received considerable attention because of the finding that many cancer cell types are sensitive to TRAIL-induced apoptosis. However, increasing experimental evidence shows that TRAIL exhibits regulatory roles in various normal tissues, as well. Although the best-characterized biological activity of TRAIL is in the homeostatic regulation of the immune system, in this review we have summarized and discussed the physiological function of TRAIL and its receptors, in normal hematopoiesis and vascular physiopathology.

KW - Endothelial cells

KW - Hematopoiesis

KW - OPG

KW - TRAIL

KW - TRAIL receptors

UR - http://www.scopus.com/inward/record.url?scp=33745854287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745854287&partnerID=8YFLogxK

U2 - 10.1016/j.cytogfr.2006.04.002

DO - 10.1016/j.cytogfr.2006.04.002

M3 - Article

C2 - 16750931

AN - SCOPUS:33745854287

VL - 17

SP - 245

EP - 257

JO - Cytokine and Growth Factor Reviews

JF - Cytokine and Growth Factor Reviews

SN - 1359-6101

IS - 4

ER -